Brimonidine Tartrate [brimonidin tartarát]
topical
5
- Terms
-
Alphagan
Luxfen
-
5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate
5-bromo-6-(imidazolidinylideneamino)quinoxaline
5-bromo-6-(imidazolin-2-ylamino)quinoxaline
AGN 190342
AGN-190342
Alphagan
Alphagan P
Brimonidine
Brimonidine Purite
Brimonidine Tartrate (1:1)
Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer
Brimonidine Tartrate, (R-(R*,R*))-Isomer
Bromoxidine
Mirvaso
Ratio-Brimonidine
Sanrosa
UK 14,304
UK 14,304-18
UK 14304
UK 14308
UK-14,304-18
UK-14,308
UK-14304
Persistent link
https://www.medvik.cz/link/D000068438
Definition
A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
- DUI
- D000068438 MeSH Browser
- CUI
- M0065049
- CAS
- 6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- History note
- 2016 (1978)
- Public note
- 2016; BRIMONIDINE TARTRATE was indexed under QUINOXALINES 1980-2015, and under IMIDAZOLES 1978-1980
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects 2
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 3
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.633.100.857.070.500
Brimonidine Tartrate, Timolol Maleate Drug Combination